A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor that can be used to treat a variety of RNA virus infections, is expected to be an effective treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. On May 1, 2020, The U.S. Food and Drug Adminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chengyuan, Tian, Lei, Liu, Yuzhi, Hui, Nan, Qiao, Guaiping, Li, Han, Shi, Zhenfeng, Tang, Yonghong, Zhang, Dezhu, Xie, Xiaolin, Zhao, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834743/
https://www.ncbi.nlm.nih.gov/pubmed/32563812
http://dx.doi.org/10.1016/j.ejmech.2020.112527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834743/
https://www.ncbi.nlm.nih.gov/pubmed/32563812
http://dx.doi.org/10.1016/j.ejmech.2020.112527

Ejemplares similares